Skip to search formSkip to main contentSkip to account menu

Chymodiactin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Chymopapain

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
The degradation of aggrecan by the different proteinases present in chymodiactin. Proceedings 1st European Symposium of the Protein Society, Davos, Switzerland
1995
1995
Kinetic constants for the hydrolysis of aggrecan by the papaya proteinases and their relevance for chemonucleolysis.
1993
1993
Aseptic spondylodiscitis: a complication of chemonucleolysis? A case report.
Discitis after intradiscal injection of chymodiactin is nearly always associated with an infection introduced by the needle tip… 
1991
1991
Cervical chemonucleolysis: a study of 130 cases
The authors present a series of 130 patients who have undergone cervical chemonucleolysis. All had experienced cervicobrachial… 
1987
1987
Chymopapain, results with chymodiactin.
1986
1986
[Clinical evaluation of Chymodiactin and post-marketing surveillance].
After a short summary of the development of chemonucleolysis technique and of Chymodiactin, the result of a randomized double… 
1986
1986
Klinische Prüfung von Chymodiactin® und Post-Marketing Surveillance
After a short summary of the development of chemonucleolysis technique and of Chymodiactin, the result of a randomized double… 
1985
1985
Use of prophylactic combined H1 and H2 antagonists reduces mortality in chymopapain anaphylaxis.
1983
1983
Animal studies and clinical trials of chymodiactin® (chymopapain).
The comparative toxicology studies using chymopapain (Discase®) versus the refined form of chymopapain (Chymodiactin®) are… 
1983
1983
Chymodiactin (chymopapain): sterile powder for injection in vials.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)